NDC 0093-5150
Moexipril Hydrochloride
Moexipril Hydrochloride
Moexipril Hydrochloride is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Moexipril Hydrochloride.
Product ID | 0093-5150_47bb5b1f-0ee0-469f-9fcc-fc3087b2e865 |
NDC | 0093-5150 |
Product Type | Human Prescription Drug |
Proprietary Name | Moexipril Hydrochloride |
Generic Name | Moexipril Hydrochloride |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2003-05-08 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA076204 |
Labeler Name | Teva Pharmaceuticals USA, Inc. |
Substance Name | MOEXIPRIL HYDROCHLORIDE |
Active Ingredient Strength | 15 mg/1 |
Pharm Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |